Abstract:Bruton tyrosine kinase (Btk) is not only critical for B cell development and differentiation but is also involved in the regulation of Toll-like receptor-triggered innate response of macrophages. However, whether Btk is involved in the regulation of natural killer (NK) cell innate function remains unknown. Here, we show that Btk expression is up-regulated during maturation and activation of mouse NK cells. Murine Btk−/− NK cells have decreased innate immune responses to the TLR3 ligand, with reduced expressions of IFN-γ, perforin, and granzyme-B and decreased cytotoxic activity. Furthermore, Btk is found to promote TLR3-triggered NK cell activation mainly by activating the NF-κB pathway. Poly(I:C)-induced NK cell-mediated acute hepatitis was observed to be attenuated in Btk−/− mice or the mice with in vivo administration of the Btk inhibitor. Correspondingly, liver damage was aggravated in Btk−/− mice after the adoptive transfer of Btk+/+ NK cells, further indicating that Btk-mediated NK cell activation contributes to TLR3-triggered acute liver injury. Importantly, reduced TLR3-triggered activation of human NK cells was observed in Btk-deficient patients with X-linked agammaglobulinemia, as evidenced by the reduced IFN-γ, CD69, and CD107a expression and cytotoxic activity. These results indicate that Btk is required for activation of NK cells, thus providing insight into the physiological significance of Btk in the regulation of immune cell functions and innate inflammatory response.Background: Whether Btk is involved in the regulation of NK cell innate function remains unknown.Results: Btk−/− murine and human NK cells have decreased innate immune responses to the TLR3 ligand.Conclusion: Btk is required for activation of NK cells.Significance: Our results provide mechanistic insight into TLR3-triggered NK cell activation and make Btk a considerable target of the anti-inflammatory drug.

BLNK expression is essential for IL-10 production in regulatory B cells that inhibit contact hypersensitivity

IKKβ increases neuropilin-2 and promotes the inhibitory function of CD9+ Bregs to control allergic diseases

BLNK negatively regulates innate antifungal immunity through inhibiting c-Cbl-mediated macrophage migration

Down-regulation of B Cell Receptor Signaling by Hematopoietic Progenitor Kinase 1 (HPK1)-mediated Phosphorylation and Ubiquitination of Activated B Cell Linker Protein (BLNK)

BLT1 Signaling in Epithelial Cells Mediates Allergic Sensitization Via Promotion of IL‐33 Production

A Notch/STAT3-driven Blimp-1/c-Maf-dependent molecular switch induces IL-10 expression in human CD4+ T cells and is defective in Crohn´s disease patients

Negative Regulation of Cd40-Mediated B Cell Responses by E3 Ubiquitin Ligase Casitas-B-Lineage Lymphoma Protein-B

Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response

Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance

BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis.

Correction: Tyrosine kinase Btk is required for NK cell activation.

Integrin CD11b negatively regulates BCR signalling to maintain autoreactive B cell tolerance

BCL-6 suppresses miR-142-3p/5p expression in SLE CD4<SUP>+</SUP> T cells by modulating histone methylation and acetylation of the miR-142 promoter

Cbl-b restrains priming of pathogenic Th17 cells via the inhibition of IL-6 production by macrophages

Lipopolysaccharide Attenuates CD40 Ligand-Induced Regulatory B10 Cell Expansion and IL-10 Production in Mouse Splenocytes

BCL-6 suppresses miR-142-3p/5p expression in SLE CD4 + T cells by modulating histone methylation and acetylation of the miR-142 promoter

Lymphotoxin-expressing Marginal Zone B Cells Support Marginal Zone Integrity by Maintaining the Megakaryoblastic Leukemia-1 Expression (BA4P.221)

NF-κB Downregulates Cbl-b Through Binding and Suppressing Cbl-b Promoter in T Cell Activation.

Regulation of CD11b by HIF-1α and the STAT3 signaling pathway contributes to the immunosuppressive function of B cells in inflammatory bowel disease.

Regulation of cytokine expression by an autoreactive B cell clone derived from MRL/MP-lpr/lpr mice